Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2020.07.07
关于境外上市外资股（H股）配发结果的公告
2020.07.07
ARTICLES OF ASSOCIATION
2020.07.07
TERMS OF REFERENCE OF SPECIAL COMMITTEES OF THE BOARD OF DIRECTORS OF SHENZHEN H...
2020.07.07
TERMS OF REFERENCE OF SPECIAL COMMITTEES OF THE BOARD OF DIRECTORS OF SHENZHEN H...
2020.07.07
TERMS OF REFERENCE OF SPECIAL COMMITTEES OF THE BOARD OF DIRECTORS OF SHENZHEN H...
2020.07.07
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
2020.07.07
TERMS OF REFERENCE OF SPECIAL COMMITTEES OF THE BOARD OF DIRECTORS OF SHENZHEN H...
2020.07.03
关于境外上市外资股（H股）公开发行价格的公告
2020.07.02
Price Determination
2020.06.30
2016年公司债券受托管理事务报告（2019年度）
第一页
上一页
59
60
61
62
63
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
